Clinical Trials for Crinetics Pharmaceuticals

Explore 10 clinical trials worldwide

Showing 1-10 of 10 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Crinetics Pharmaceuticals

Clinical Trials (10)

NCT07087054
Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen
PHASE3Recruiting
141 participants
Started: Oct 31, 2025 · Completed: Jan 31, 2030
9 conditions1 sponsor10 locations
NCT07129252
A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors
PHASE1/PHASE2Not yet recruiting
150 participants
Started: Oct 31, 2025 · Completed: Aug 31, 2029
3 conditions1 sponsor0 locations
NCT07159841
A Study in Pediatric Participants With Congenital Adrenal Hyperplasia (Balance-CAH)
PHASE2/PHASE3Not yet recruiting
153 participants
Started: Sep 30, 2025 · Completed: Mar 31, 2030
2 conditions1 sponsor0 locations
NCT07144163
A Study to Evaluate Atumelnant in Adults With Congenital Adrenal Hyperplasia
PHASE3Not yet recruiting
150 participants
Started: Sep 30, 2025 · Completed: May 31, 2027
2 conditions1 sponsor5 locations
NCT06712823
An Extension Study to Evaluate Safety and Efficacy in Participants Treated With CRN04894
PHASE2Recruiting
150 participants
Started: Feb 25, 2025 · Completed: Nov 30, 2027
2 conditions1 sponsor9 locations
NCT05804669
A Study to Evaluate the Safety and PK of CRN04894 for the Treatment of Cushing's Syndrome
PHASE1/PHASE2Recruiting
18 participants
Started: Oct 12, 2023 · Completed: Oct 31, 2026
3 conditions1 sponsor1 location
NCT05361668
Study to Evaluate the Safety, PK, and Dose Response of Paltusotine in Subjects With Carcinoid Syndrome
PHASE2Active, not recruiting
36 participants
Started: Jun 17, 2022 · Completed: Feb 28, 2026
9 conditions1 sponsor35 locations
NCT05192382
A Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (PATHFNDR-2)
PHASE3Active, not recruiting
111 participants
Started: Dec 17, 2021 · Completed: Jan 31, 2028
1 condition1 sponsor57 locations
NCT04837040
A Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly
PHASE3Active, not recruiting
58 participants
Started: May 12, 2021 · Completed: Jun 30, 2027
1 condition1 sponsor39 locations
NCT04261712
A Study to Evaluate the Long-Term Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (ACROBAT Advance)
PHASE2Active, not recruiting
43 participants
Started: Jan 29, 2019 · Completed: Mar 31, 2028
1 condition1 sponsor21 locations